Company Profile

Reveal Biosciences Inc
Profile last edited on: 7/1/21      CAGE: 6TK86      UEI: HEEAZ9FXXM13

Business Identifier: “AI-Powered” Pathology: advanced pathology for preclinical research, clinical trials, and decision supp
Year Founded
First Award
Latest Award
Program Status
Active (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

6760 Top Gun Street Unit 110
San Diego, CA 92121
   (858) 274-3663
Location: Single
Congr. District: 52
County: San Diego

Public Profile

Reveal Biosciences is a computational pathology company combining traditional histopathology with machine learning to address enabling tissue biology to yield actionable data. The firm's technology pipeline includes a high-plex multiplex platform and machine learning computational pathology solutions to benefit cancer patients. Reveal provides advanced tissue technologies including immunohistochemistry (IHC), in situ hybridization (ISH), histology, digital pathology and image analysis services to a broad range of pharmaceutical, biotech, academic and government institutions. In May 2021 it was announced that Reveal Biosciences had been acquired by the Canadian firm CellCarta for an undisclosed amount.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Claire Weston -- Founder and CEO

  Casey Laris -- Founder and CTO

  Ami Lau -- Director of Operations

  Ivana Mikic -- Director of AI Operations